Winshine Science Co (HKSE:00209) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Winshine Science Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Winshine Science Co's long-term debt to total assets ratio declined from Dec. 2022 (0.01) to Dec. 2023 (0.00). It may suggest that Winshine Science Co is progressively becoming less dependent on debt to grow their business.

Winshine Science Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Winshine Science Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winshine Science Co LT-Debt-to-Total-Asset Chart

Winshine Science Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.02

0.01

Winshine Science Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.02	0.01	0.01	0.01	-

Winshine Science Co LT-Debt-to-Total-Asset Calculation

Winshine Science Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1.858	/	414.325
	=	0.00

Winshine Science Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	1.858	/	414.325
	=	0.00

Winshine Science Co (HKSE:00209) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Winshine Science Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Winshine Science Co (HKSE:00209) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG

Website

http://www.winshine.com

Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.

Executives

Wang Honggang	2101 Beneficial owner
U Credit (hk) Limited	2106 Person having a security interest in shares
Csc Holdings Limited	2106 Person having a security interest in shares
Hurray Talent Investment Development Limited	2101 Beneficial owner
Li Zhonghai	2201 Interest of corporation controlled by you
Liu Lian	2201 Interest of corporation controlled by you
Richsun Investment Development Limited	2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited	2101 Beneficial owner
Jiang Qinghui	2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited")	2106 Person having a security interest in shares
China Strategic Holdings Limited	2106 Person having a security interest in shares
Shen Jia	2101 Beneficial owner

Winshine Science Co (HKSE:00209) Headlines

No Headlines